Filing Details

Accession Number:
0001127602-19-033198
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-19 16:08:37
Reporting Period:
2019-11-15
Accepted Time:
2019-11-19 16:08:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1560152 A. John Fallon C/o Insulet Corporation
100 Nagog Park
Acton MA 01720
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-15 5,000 $21.35 18,469 No 4 M Direct
Common Stock Disposition 2019-11-15 5,000 $180.07 13,469 No 4 S Direct
Common Stock Acquisiton 2019-11-18 5,525 $27.37 18,994 No 4 M Direct
Common Stock Acquisiton 2019-11-18 4,000 $30.04 22,994 No 4 M Direct
Common Stock Disposition 2019-11-18 9,525 $181.41 13,469 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-11-15 5,000 $0.00 5,000 $21.35
Common Stock Stock Option (Right to Buy) Disposition 2019-11-18 5,525 $0.00 5,525 $27.37
Common Stock Stock Option (Right to Buy) Disposition 2019-11-18 4,000 $0.00 4,000 $30.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-11-01 No 4 M Direct
0 2025-05-13 No 4 M Direct
0 2023-06-03 No 4 M Direct
Footnotes
  1. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $181.18 to $182.82. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  2. This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant.
  3. This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2016, 25% of the total award vesting on April 30, 2017 and 25% of the total award vesting on April 30, 2018, subject to continued service as a director or consultant.
  4. This option is subject to the following vesting schedule: 50% of the total award shall vest on April 30, 2014, 25% of the total award shall vest on April 30, 2015 and 25% of the total award shall vest on April 30, 2016, subject to continued service as a director or consultant.